New search Hide text from Guidelines
N NERVOUS SYSTEMN04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
| The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease. No separate DDDs are established for oral depot formulations. |
N04A ANTICHOLINERGIC AGENTS
N04AA Tertiary amines
| ATC code | Name | DDD | U | Adm.R | Note |
| N04AA01 | trihexyphenidyl | 10 | mg | O | |
| N04AA02 | biperiden | 10 | mg | O | |
| 10 | mg | P | |||
| N04AA03 | metixene | 40 | mg | O | |
| N04AA04 | procyclidine | 25 | mg | O | |
| 25 | mg | P | |||
| N04AA05 | profenamine | ||||
| N04AA08 | dexetimide | 0.5 | mg | O | |
| 0.125 | mg | P | |||
| N04AA09 | phenglutarimide | ||||
| N04AA10 | mazaticol | ||||
| N04AA11 | bornaprine | ||||
| N04AA12 | tropatepine |
Last updated: 2024-01-26